Sentrx Animal Care

What Sentrx Animal Care does

Sentrx Animal Care, legally Dômes Pharma Inc. since the October 2024 acquisition and rebrand, is a Salt Lake City-based veterinary health product manufacturer specializing in ophthalmic solutions for companion animals. The company was founded in 2006, operates as a private corporation with 11-50 employees, and is led by President Anne Moulin alongside CEO Richard K. Koehn, COO Sarah K. Atzet, and co-founder and science advisor Glenn Prestwich.

Its product line is built on a single proprietary platform, BioHAnce, a patented cross-linked Hyaluronic Acid (HA) technology engineered to form a long-lasting protective barrier on the ocular surface, providing physical support and extended duration beyond what traditional HA formulations achieve. Commercial SKUs under this umbrella include Ocunovis ProCare BioHAnce Gel Eye Drops, Oculenis BioHAnce Corneal Gel, Eye Lube Pro, Fluodrop, and Ocryl Ocular Cleanser. The portfolio carries ISO quality certifications and Fear Free Preferred Products designation from Fear Free LLC, signaling regulatory compliance and commitment to low-stress veterinary visits.

Commercially, the company operates a focused B2B go-to-market, selling exclusively through a U.S.-only network of Authorized Veterinary Distributors for clinical channels and the Vet's First Choice online veterinary pharmacy for prescription fulfillment to pet owners. Revenue is generated through product sales with no disclosed pricing or subscription model, and marketing is concentrated around veterinary continuing education, podcast content, and an interactive Ocular Immersion educational tool aimed at veterinary practices rather than direct consumer advertising.

Name

Sentrx Animal Care

Legal name

Dômes Pharma, Inc.

Website

https://sentrxanimalcare.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

11–50 employees

Short description

Dômes Pharma Inc. (formerly Sentrx Animal Care) is a Salt Lake City-based veterinary health manufacturer selling ophthalmic products built on its patented BioHAnce cross-linked Hyaluronic Acid platform, distributed via U.S. authorized veterinary distributors and the Vet's First Choice online pharmacy to veterinary practices and pet owners.

Ownership category

akta.pro rank

Product category

Veterinary Ophthalmic Products

akta.pro primary industry

Companion Animal Therapeutics (Rx) (HLAMAEAA)

Keywords

• Veterinary ophthalmology products
• Animal eye care
• Hyaluronic acid technology
• Veterinary pharmaceuticals
• Ocular surface treatment

Headquarters

HQ city

Salt Lake City

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Veterinary Pharmaceutical Products: Sale of ophthalmic solutions and ocular care products for animals through veterinary distribution channels. Products include eye drops, corneal gels, ocular cleansers, and eye lubricants for pets.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Sentrx Animal Care manufactures and sells a portfolio of veterinary ophthalmic products for companion animals, including eye drops, corneal gels, ocular cleansers, and lubricants, all built on its patented BioHAnce cross-linked Hyaluronic Acid technology. The products are designed to provide extended ocular surface protection and natural recovery for veterinary clinical use, and are certified as Fear Free Preferred Products.

Product overview

Sentrx Animal Care (now Dômes Pharma Inc.) offers a portfolio of veterinary ophthalmic products centered around its proprietary BioHAnce Technology platform. The product line includes Ocunovis ProCare BioHAnce Gel Eye Drops, Oculenis BioHAnce Corneal Gel, Eye Lube Pro, Fluodrop, and Ocryl Ocular Cleanser. These products form a cohesive ocular care ecosystem united by the patented BioHAnce cross-linked Hyaluronic Acid technology, which creates a long-lasting protective barrier for the ocular surface. The company also holds Fear Free Preferred certification for its products, emphasizing stress-free pet care solutions.

Differentiator

Problem solved

Functional benefit

Brands

• BioHAnce: Patented crosslinked Hyaluronic Acid technology platform used in Dômes Pharma's ophthalmic products.
• Ocunovis
• Oculenis

Products and services

• Ocunovis ProCare BioHAnce Gel Eye Drops A veterinary ophthalmic gel eye drop using patented BioHAnce cross-linked Hyaluronic Acid technology, designed to provide extended protection and support for dry and irritated eyes in companion animals.
• Oculenis BioHAnce Corneal Gel A corneal gel formulation using BioHAnce technology to support ocular surface recovery and provide physical protection for the cornea in companion animals.
• Eye Lube Pro A veterinary ocular lubricant product for companion-animal eye care.
• Fluodrop A veterinary ophthalmic drop product for animal eye care.
• Ocryl Ocular Cleanser An ocular cleansing solution for veterinary use in companion animals.
• BioHAnce Technology Platform Patented cross-linked Hyaluronic Acid technology platform that forms a long-lasting protective barrier on the ocular surface, providing physical support and extended duration beyond traditional HA. Marketed as a standalone branded technology page on the company website.

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Fear Free LLCcoreGTM or Marketing PartnerFear Free Preferred Products partnership designates Dômes Pharma/Sentrx ophthalmic solutions as certified products that support stress-free veterinary visits. This partnership validates the company's commitment to pet comfort and anxiety-reducing veterinary care.

Recent moves6 records

Expansion highlights4 records

Direct peers

• I-MED Animal Health: I-MED Animal Health is a Canadian veterinary ophthalmology company selling ocular drugs and devices to companion-animal practices — the closest U.S./North America comparable to Sentrx's product mix and customer base.

Broad incumbents

• Dechra Pharmaceuticals: Dechra is a UK-based specialty veterinary pharmaceutical company with an established ophthalmology portfolio alongside endocrinology, dermatology, and other therapeutic categories — directly comparable as a specialty vet pharma competitor in ophthalmology.
• Virbac: Virbac is a global animal health company with companion-animal ophthalmology products sold through veterinary distributors — a broad incumbent overlapping Sentrx's therapeutic area, customer base, and distribution model.
• Vetoquinol: Vetoquinol is a French veterinary pharmaceutical company offering specialty products to companion-animal practices, including ophthalmology — directly comparable given the shared French heritage and veterinary specialty focus.
• Ceva Santé Animale: Ceva is a global veterinary health company with companion-animal pharmaceutical products, including ophthalmology lines, sold via veterinary distribution — comparable in business model, distribution, and therapeutic focus.
• Zoetis: Zoetis is the world's largest animal health company with a broad companion-animal portfolio including ophthalmology — a relevant scale competitor in U.S. veterinary clinics and a benchmark for the company's addressable market.
• Elanco Animal Health: Elanco is a major global animal health company with companion-animal ophthalmology and dermatology franchises distributed through U.S. vet channels — comparable as a broad incumbent competing for the same veterinary shelf space.
• Boehringer Ingelheim Animal Health: Boehringer Ingelheim's animal health business includes companion-animal pharmaceuticals distributed via U.S. veterinary channels — overlapping with Sentrx on distribution, customer base, and parts of the therapeutic portfolio.
• Merck Animal Health: Merck Animal Health is a global animal health company with companion-animal pharmaceuticals distributed through U.S. vet distributors — comparable on channel structure and customer base, even where specific ophthalmology overlap is partial.
• Bausch + Lomb (Animal Care): Bausch + Lomb has historically produced veterinary ophthalmology products adjacent to its human ophthalmology franchise — highly comparable technology and product category, broader portfolio, and overlapping customer base in companion-animal eye care.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sentrx Animal Care